Assessment of Occult Lung Stress During Lung Protective Mechanical Ventilation
NCT ID: NCT05675696
Last Updated: 2025-04-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2024-10-31
2025-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Change In Diaphragmatic Thickness Predicts Extubation Success
NCT02656199
ARDS Esophageal Balloon Pressure Changes With Positioning Study
NCT03120793
Esophageal Pressure Measurements During One-lung Ventilation
NCT04725318
Mechanical Ventilation, Directed by Esophageal Pressure Measurements, in Patients With Acute Lung Injury
NCT00127491
The Utility of Regional Bioimpedance in Chronically Ventilated Patients
NCT02951936
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ARDS Patients Intubated on Mechanical Ventilation
ARDS patients in the ICU who are intubated on mechanical ventilation will be included. During ventilation, an esophageal catheter will be used to measure the esophageal pressure, which estimates pleural pressure at the level of the catheter. The esophageal catheter's position will be confirmed by a chest radiograph once inserted. The ventilator settings may be changed to see if these ventilator adjustments can reduce potential lung stress in ARDS patients. There is no set criteria for adjusting the ventilator settings based on the study device, but the goal would be to adjust the volume until the inspiratory effort measured by the catheter disappears so as to protect the patient. A one-to-two-hour study session will be performed for data collection. The esophageal catheter will be removed at the end of the study session or can be left in place for use as a feeding tube if needed for patient care.
Esophageal Catheter
Newly designed external monitor that will capture esophageal pressure from a proprietary nasogastric tube combined with simultaneous pressure, flow, and volume measurements from the ventilator tubing.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Esophageal Catheter
Newly designed external monitor that will capture esophageal pressure from a proprietary nasogastric tube combined with simultaneous pressure, flow, and volume measurements from the ventilator tubing.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Meets Berlin criteria for ARDS, with or without underlying chronic lung disease
* Triggering breaths on the ventilator
* Treating medical team agrees with patient participation
Exclusion Criteria
* Shock that requires ≥ 2 vasopressors
* pH on arterial blood gas ≤7.25
* Minute ventilation ≥ 14L/min
* Known or suspected pneumothorax, pneumomediastinum, and/or subcutaneous emphysema
* Severe ARDS with P/F ratio \<60
* Pregnancy
* Currently receiving extracorporeal membrane oxygenation (ECMO) therapy
* Decision to withhold life-sustaining treatment
* Patients who are not expected to survive for 24 hours
* Lack of informed consent
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
NYU Langone Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Beno Oppenheimer, MD
Role: PRINCIPAL_INVESTIGATOR
NYU Langone Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tisch Hospital
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
22-00695
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.